Abstract
Numerous studies have highlighted the potential of aluminium as an aetiological factor for some neurodegenerative disorders, particularly Alzheimer’s disease and Parkinson’s disease. Our previous studies have shown that aluminium can cause oxidative stress, reduce the activity of some antioxidant enzymes, and enhance the dopaminergic neurodegeneration induced by 6-hydroxydopamine in an experimental model of Parkinson’s disease in rats. We now report a study on the effects caused by aluminium on mitochondrial bioenergetics following aluminium addition and after its chronic administration to rats. To develop our study, we used a high-resolution respirometry to test the mitochondrial respiratory capacities under the conditions of coupling, uncoupling, and non-coupling. Our study showed alterations in leakiness, a reduction in the maximum capacity of complex II-linked respiratory pathway, a decline in the respiration efficiency, and a decrease in the activities of complexes III and V in both models studied. The observed effects also included both an alteration in mitochondrial transmembrane potential and a decrease in oxidative phosphorylation capacity when relatively high concentrations of aluminium were added to the isolated mitochondria. These findings contribute to explain both the ability of aluminium to generate oxidative stress and its suggested potential to act as an etiological factor by promoting the progression of neurodegenerative disorders such as Parkinson’s disease.
Similar content being viewed by others
Abbreviations
- Al3+ :
-
Aluminium
- ANT:
-
Adenine nucleotide translocator
- CI:
-
Complex I
- CII:
-
Complex II
- E:
-
Uncoupled state
- ETS:
-
Electron transport system
- ETSmax :
-
Non-coupled respiration
- FCCP:
-
Carbonyl cyanide-4-(trifluoromethoxy)-phenylhydrazone
- L:
-
Resting state after ATP synthase inhibition
- mPTP:
-
Mitochondrial permeability transition pore
- OXPHOS:
-
Oxidative phosphorylation
- P:
-
ADP activated state
- PD:
-
Parkinson’s disease
- ROS:
-
Reactive oxygen species
- SOD:
-
Superoxide dismutase
- SUIT:
-
Substrate-uncoupler-inhibitor-titration
- TCA:
-
Tricarboxylic acid cycle
- TTP+ :
-
Tetraphenylphosphonium
- Δψ:
-
Mitochondria transmembrane potential
References
Exley C (2013) Human exposure to aluminium. Environ Sci Processes Impacts 15:1807–18016
House E, Esiri M, Forster G, Ince PG, Exley C (2012) Aluminium, iron and copper in human brain tissues donated to the Medical Research Council’s Cognitive Function and Ageing Study. Metallomics 4:56–65
Hirsch EC, Brandel JP, Galle P, Javoy-Aqid F, Aqid Y (1991) Iron and aluminium increase in the substantia nigra of patients with Parkinson’s disease: a X-ray microanalysis. J Neurochem 56:446–451
Yasui M, Kihira T, Ota K (1992) Calcium, magnesium and aluminium concentrations in Parkinson’s disease. Neurotoxicology 13:593–600
Miu AC, Andreescu CE, Vaius R, Oltenau AI (2003) A behavioural and histological study of the effects of long-term exposure of adults rats to aluminium. Int J Neurosci 113:1197–1211
Julka D, Sandhir R, Gill KD (1995) Altered cholinergic metabolism in rat CNS following aluminium exposure: implications on learning performance. J Neurochem 65:2157–2164
Robertson JA, Felsenfeld AJ, Haygood CC, Wilson P, Clarke C, Llach F (1983) Animal model of alumium-induced osteomalacia: role of chronic renal failure. Kidney Int 23:327–335
Bolla KI, Briefel G, Spector D, Schwartz BS, Wieler L, Herron J, Gimenez L (1992) Neurocognitive effects of aluminium. Arch Neurol 49:1021–1026
Perl DP, Gajdusek DC, Garruto RM, Yanagihara RT, Gibbs CJ (1982) Intraneuronal aluminium accumulation in amyotrophic lateral sclerosis and Parkinsonism-demaentia of Guam. Science 10:1053–1055
Garruto RM, Fukatsu R, Yanagihara R, Gajdusek DC, Hook G, Fiori CE (1984) Imaging of calcium and aluminium in neurofibrillary tangle-bearing neurons in parkinsonism-dementia of Guam. Proc Natl Acad Sci U S A 81:1875–1879
Zatta P, Lucchini R, Van Rensburg SJ, Taylor A (2003) The role of metals in neurodegenerative processes: aluminium, manganese and zinc. Brain Res Bull 62:15–28
Walton JR (2006) Aluminium in hippocampal neurons from humans with Alzheimer’s disease. Neurotoxicology 27:385–394
Bondy SC, Ali SF, Guo-Ross S (1998) Aluminium but not iron treatment induces pro-oxidant events in the rat brain. Mol Chem Neuropathol 34:219–232
Kumar V, Gill KD (2009) Aluminium neurotoxicity: neurobehavioural and oxidative aspects. Arch Toxicol 83:965–978
Wu Z, Du Y, Xue H, Wu Y, Zhou B (2012) Aluminum induces neurodegeneration and its toxicity arises from increased iron accumulation and reactive oxygen species (ROS) production. Neurobiol Aging 33:199.e1–199.e12
Sánchez-Iglesias S, Soto-Otero R, Iglesias-González J, Barciela-Alonso MC, Bermejo-Barrera P, Méndez-Álvarez E (2007) Analysis of brain regional distribution of aluminium in rats via oral and intraperitoneal administration. J Trace Elem Med Biol 21:31–34
Sánchez-Iglesias S, Méndez-Álvarez E, Iglesias-González J, Muñoz-Patiño A, Sánchez-Sellero I, Labandeira-García JL, Soto-Otero R (2009) Brain oxidative stress and selective behaviour of aluminium in specific areas of rat brain: potential effects in a 6-OHDA-induced model of Prakinson’s disease. J Neurochem 109:879–888
Gaeta A, Hider RC (2005) The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy. Br J Pharmacol 146:1041–1059
Ward RJ, Dexter DT, Crichton RR (2012) Chelating agents for neurodegenerative diseases. Curr Med Chem 19:2760–2772
Levenson CW (2003) Iron and Parkinson’s disease: chelators to rescue? Nutr Rev 61:311–313
Youdim MB, Stephenson G, Ben Sachar D (2004) Ironing iron out in Parkinson’s disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28. Ann NY Acad Sci 1012:306–325
Cadenas E (2004) Mitochondrial free radical production and cell signaling. Mol Asp Med 25:17–26
Kowaltowski AJ, de Souza-Pinto NC, Castilho RF, Vercesi AE (2009) Mitochondria and reactive oxygen species. Free Radic Biol Med 47:333–343
Chandel NS (2014) Mitochondria as signaling organelles. BMC Biol 12:34
Schapira AHV, Cooper JM, Dexter D, Jenner P, Clark JB, Mardsen CD (1989) Mitochondrial complex I deficiency in Parkinson’s disease. Lancet 1:1269
Keeney PM, Xie J, Capaldi RA, Bennett JP Jr (2006) Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci 26:5256–5264
Dauer W, Przedborski S (2003) Parkinson’s disease: mechanisms and models. Neuron 39:889–909
Cannon JR, Greenamyre JT (2013) Gene-environment interactions in Parkinson’s disease: specific evidence in humans and mammalian models. Neurobiol Dis 57:38–46
Schapira AHV (2008) Mitochondria in the aetiology and pathogenesis of Parkinson’s disease. Lancet Neurol 7:97–109
Kumar V, Bal A, Gill KD (2008) Impairment of mitochondrial energy metabolism in different regions of rat brain following chronic exposure to aluminium. Brain Res 1232:94–103
Tonitello A, Clari G, Mancon M, Tognon G, Zatta P (2000) Aluminium as inducer of the mitocondrial permeability transition. J Biol Inorg Chem 5:612–623
Exley C (2004) The pro-oxidant activity of aluminium. Free Radic Biol Med 36:380–387
Schapiro SA, Everitt JI (2006) Preparation of animals for use in the laboratory: issues and challenges for the Institutional Animal Care and Use Committee (IACUC). ILAR J 47:370–375
Iglesias-Gonzalez J, Sánchez-Iglesias S, Beiras-Iglesias A, Soto-Otero R, Méndez-Álvarez E (2013) A simple method for isolating rat brain mitochondria with high metabolic activity: Effects of EGTA and EDTA. J Neurosci Methods 213:39–42
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Fasching M, Gnaiger E (2009) Determination of membrane potential with TPP+ and an ion selective electrode. Mitochondr Physiol Network 14(5):1–7
Manella CA (2006) Structure and dynamics of the mitochondrial inner membrane cristae. Biochim Biophys Acta 1763:542–548
Gnaiger E (2009) Capacity of oxidative phosphorylation in human skeletal muscle. New perspectives of mitochondrial physiology. Int J Biochem Cell Biol 41:1837–1845
Lin MT, Beal MF (2003) The oxidative damage theory of aging. Clin Neurosci Res 2:305–315
Daiber A (2010) Redox signalling (cross-talk) from and to mitochondria involves mitochondrial pores and reactive oxidative species. Biochim Biophys Acta 1797:897–906
Le Masters JJ, Nieminen A-L, Quian T, Lawrence C, Elmore SP, Nishimura Y, Crowe RA, Cascio WE et al (1998) The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta 1366:177–196
De Marchi U, Mancon M, Battaglia V, Ceccon S, Cardellini P, Tonitello A (2004) Influence of reactive oxygen species production by monoamine oxidase activity on aluminium-induced mitochondrial permeability transition. Cell Mol Life Sci 61:2664–2671
Van Rensburg SJ, Carstens ME, Potocnik FCV, Aucamp AK, Taljaard JJF, Koch KR (1992) Membrane fluidity of platelets and erythrocytes in patients with Alzheimer’s disease and the effect of small amounts of aluminium on platelet and erythrocytes membranes. Neurochem Res 17:825–829
Bleier L, Dröse S (2012) Superoxide generation by complex III: from mechanistic rationales to functional consequences. Biochim Biophys Acta 1827:1320–1331
Swegert CV, Dave KR, Katyare SS (1999) Effect of aluminium-induced Alzheimer like condition on oxidative energy metabolism in rat liver, brain and heart mitochondria. Mech Aging Develop 112:27–42
Mailloux RJ, Hamel R, Appanna VD (2006) Aluminium toxicity elicits a dysfunctional TCA cycle and succinate accumulation in hepatocytes. J Biochem Mol Toxicol 20:198–208
Trapp GA (1980) Studies on aluminium interaction with enzymes and proteins-the inhibition of hexokinase. Neurotoxicology 1:89–100
Zatta P, Lain E, Cagnolini C (2000) Effects of aluminium on activity of Krebs cycle enzymes and glutamate dehydrogenase in rat brain homogenate. Eur J Biochem 267:3049–3055
Bolam JP, Pissadaki EK (2012) Living on the edge with too many mouths to feed: why dopamine neurons die. Mov Disord 27:1478–1483
Acknowledgments
This study was financially supported by grant 09CSA005298PR from the Galician Government (XUGA), Santiago de Compostela, Spain.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Iglesias-González, J., Sánchez-Iglesias, S., Beiras-Iglesias, A. et al. Effects of Aluminium on Rat Brain Mitochondria Bioenergetics: an In vitro and In vivo Study. Mol Neurobiol 54, 563–570 (2017). https://doi.org/10.1007/s12035-015-9650-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-015-9650-z